Name: Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects (en Inglés)
Price: 421.20 PEN
Availability: InStock
Author: Shaz, Beth H. ; Hillyer, Christopher D. ; Schwartz
ISBN: 9780323960144

portada Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects (en Inglés)

Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects (en Inglés)

Formato

Libro Físico

Editorial

Elsevier Science

Autor

Shaz, Beth H. ; Hillyer, Christopher D. ; Schwartz

Idioma

Inglés

N° páginas

1000

Encuadernación

Tapa Blanda

ISBN13

9780323960144

N° edición

0004

Categorías

Hematología

Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects (en Inglés)

Shaz, Beth H. ; Hillyer, Christopher D. ; Schwartz (Autor) · Elsevier Science · Tapa Blanda

Más barato Libro Nuevo Importado

Envío: 18 a 23 días háb.

S/ 936,00S/ 421,20

-55%

Más rápido Libro Nuevo Importado

Envío: 10 a 14 días háb.

S/ 1.065,21S/ 479,35

-55%

Costos de importación incluídos en el precio ✅

Libro Nuevo Más barato

Quedan 100 unidades

S/ 421,20

Llega entre el 14 Jul y el 22 Jul a CERCADO DE LIMA, Lima. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects (en Inglés)"

Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects, Fourth Edition continues to be the only "pocket-size" quick reference for pathology and transfusion medicine for residents and fellows. It is helpful to all physicians and allied health professionals who order and administer blood components, cellular therapies, specialized factors for hemostatic abnormalities, coagulation testing, and those who consult and care for these often very ill patients. This book is ideal for pathology, medicine, surgery, and anesthesia residents, transfusion, hematology, and anesthesia fellows, and certified and specialized practitioners, as well as medical technologist in transfusion, cellular therapy, hematology, and coagulation. This new edition covers the many new developments that have occurred since the previous edition to include new blood products, new indications, or clinical conditions in which blood products are used. Similarly, new hemostasis testing is introduced as well as new clinical scenarios due the COVID-19 pandemic that area relevant to hemostasis and transfusion medicine. This includes COVID coagulopathy, Vaccine Induced Thrombotic Immune Thrombocytopenia, Pediatric reference range in coagulation testing, Platelet rich plasma and MNC products - CAR-T cells.